Drug Channels

MARCH 14, 2022

Asembia’s Specialty Pharmacy Summit 2022. Asembia's Specialty Pharmacy Summit 2022 is back! This is a must-attend event for anyone connected to specialty pharmacy. Plus, Doug Long from IQVIA and I will again lead the Featured Session, titled The Specialty Pharmacy Industry Update and Outlook. Gottlieb’s excellent book.

Specialty Pharmacies 54

Specialty Pharmacies Pharmacy FDA Science 54

Drug Channels

JUNE 1, 2020

Like many of you, I was disappointed that Asembia had to cancel its 2020 Specialty Pharmacy Summit. You can view them for FREE if your registration to the 2020 Specialty Pharmacy Summit was transferred to the 2021 Summit. Click here to register for access to Asembia’s Specialty Pharmacy Summit Virtual Experience.

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Pharmaceuticals Marketing 40

Drug Channels

OCTOBER 10, 2023

I am pleased to announce our new 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. we analyze the IRA’s likely consequences for wholesalers and the overall pharmaceutical business. and Section 6.4.3.

Pharmaceuticals 40

Pharmaceuticals Specialty Pharmacies Pharmacy Biosimilars 40

Drug Target Review

AUGUST 30, 2024

I started by studying pharmaceutical sciences with the initial plan of becoming a pharmacist and owning my own pharmacy. However, I pursued an additional year in industrial pharmacy, where I learned a lot about manufacturing and drug development, which I found really fascinating.

Pharmacy 59

Pharmacy Engineering Pharmaceuticals Science 59

Drug Channels

OCTOBER 3, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on our new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. CVS Health launched Cordavis, a new subsidiary that will market a private label, low-list-price version of Sandoz’ Hyrimoz. The Humira biosimilar market has arrived!

Biosimilars 80

Biosimilars Pharmacy Marketing Pharmaceuticals 80

Drug Channels

MAY 21, 2024

WHAT YOU WILL LEARN The federal 340B Drug Pricing Program continues to grow much more quickly than the overall pharmaceutical market. DCI estimates that 340B discounts equated to more than 17% of total value of gross-to-net reductions for brand-name pharmaceuticals. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 52

Pharmacy Drugs Pharmaceuticals Marketing 52

Drug Channels

SEPTEMBER 12, 2023

On October 10, 2023, Drug Channels Institute will release 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. pharmaceutical distribution industry. As always, we have updated all market and industry data with the most current information available.

Pharmaceuticals 52

Pharmaceuticals Pharmacy Biosimilars Licensing 52

Drug Channels

OCTOBER 2, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Click here to see the original post from May 2023. Today, I examine these PBM-owned GPOs and then speculate on five plausible explanations for their existence.

Pharmacy 72

Pharmacy Pharmaceuticals Marketing Drugs 72

Drug Channels

MAY 24, 2023

In recent years, each of these companies has launched new group purchasing organizations (GPOs) to further consolidate the number of covered lives in rebate negotiations with pharmaceutical manufacturers. Today, I examine these PBM-owned GPOs and then speculate on five plausible explanations for their existence.

Pharmacy 93

Pharmacy Pharmaceuticals Marketing Drugs 93

Perficient: Drug Development

FEBRUARY 20, 2024

Among these, pharmacy benefit managers (PBMs) play a crucial role, handling reimbursements and negotiations with drug manufacturers and pharmacies. Three major PBM players – CVS Caremark, Express Scripts, and OptumRx – collectively command a significant 79% market share , orchestrating much of the industry’s dynamics.

Pharmacy 52

Pharmacy Independent Pharmacies Doctors Pharmaceuticals 52

Drug Channels

AUGUST 8, 2023

on the overall market, explained channel distortions from 340B contract pharmacies, and offered some policy recommendations. Recently, a bipartisan group of six U.S. Click here to read the full letter. I submitted a 14-page letter, which you can read below. I shared my $0.02 How could I not? d/b/a Drug Channels Institute.

Pharmacy 71

Pharmacy Hospitals Drugs Pharmaceuticals 71

Drug Channels

APRIL 8, 2022

Michael discusses patient support challenges that are unique to specialty-lite pharmaceuticals. He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment.

Specialty Pharmacies 71

Specialty Pharmacies Production Pharmacy Therapies 71

Drug Channels

OCTOBER 23, 2023

A program driven by market dynamics and led by champions of channel strategy, join now to master the complexities of pharmacy and distribution models to accelerate market access –It's all happening December 11-13, 2023. Why should you attend this pivotal event? How is health policy affecting the distribution channel?

Pharmacy 61

Pharmacy Biosimilars Production Marketing 61

Drug Channels

OCTOBER 11, 2022

I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. examines how the Inflation Reduction Act could ultimately impact pharmaceutical wholesalers’ customers and business outlook.

Pharmaceuticals 56

Pharmaceuticals Biosimilars Licensing Licensing 56

Drug Channels

OCTOBER 5, 2021

I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. reviews AmerisourceBergen’s entry into the European distribution market. (We Section 4.4. Section 7.4.4. Section 6.1.5.

Pharmaceuticals 62

Pharmaceuticals Biosimilars Licensing Licensing 62

Drug Channels

JULY 29, 2022

Note that the forecasts below did not account for policy changes that could further reduce pharmaceuticals' share of U.S. As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. healthcare spending. spending on healthcare.

Pharmacy 84

Pharmacy Drugs Government Pharmaceuticals 84

Drug Channels

APRIL 12, 2022

As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. What’s more, taxpayers—via Medicare and Medicaid—will continue to crowd out the private insurance market. healthcare spending. healthcare spending growth.

Pharmacy 92

Pharmacy Drugs Government Pharmaceuticals 92

Fierce BioTech

DECEMBER 27, 2023

This will allow pharmaceutical companies to reach consumers directly, to reduce costs, increase efficiency, provide patients with faster access to medications, improve adherence, and create a more personalized experience. Discover the value of a white-labeled pharmacy from a marketing messaging and operational perspective.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmacy Therapies Pharmaceuticals 52

Drug Channels

MAY 22, 2023

WHAT YOU WILL LEARN As expensive specialty therapies come to dominate drug spending, pharmaceutical manufacturers are paying a growing share of patents’ out-of-pocket costs for these prescriptions. Pharmacies and Pharmacy Benefit Managers. This event is part of The Drug Channels 2023 Video Webinar Series.

Pharmacy 72

Pharmacy Drugs Marketing Therapies 72

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. As you will see below, mail and specialty pharmacies’ purchases of products that are eligible for 340B discounts have grown by an incredible 56% per year since 2017.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Pharmaceuticals 52

Drug Channels

SEPTEMBER 21, 2020

This important event convenes key stakeholders including manufacturers, specialty pharmacies, hubs, payers, PBMs, physicians and more to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and optimal reimbursement. Arquette, R.Ph., REGISTER TODAY.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Production 52

Drug Channels

OCTOBER 13, 2020

I am pleased to announce our new 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. The 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors is the only resource of its kind available anywhere. healthcare system.

Pharmaceuticals 52

Pharmaceuticals Licensing Licensing Pharmacy 52

DrugBank

SEPTEMBER 26, 2024

Due to the less extensive clinical trial requirements and the competitive nature of the biosimilar market, these biologics can be produced and marketed at significantly lower prices than their reference counterparts. Still, significant differences exist between these two major markets.

Biosimilars 74

Biosimilars Clinical Trials Production FDA 74

Drug Channels

OCTOBER 19, 2020

Channel Strategy for First Medical Product – A Look at Channel Considerations for Pharmacy vs. Medical Plus – Tailored Track Options Based on Company Size : Emerging/Small Companies – Infrastructure Set-Up, License Procurement and 3PL Contracting Mid-Large Companies – How Do I Think About My Portfolio Differently Based on Product Type?

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Licensing 52

H1 Blog

JULY 24, 2023

Strategies for Market Access Teams One thing the healthcare ecosystem lacks in the United States is a system of shareable, actionable healthcare data. How do pharmaceutical companies work with payers? So where is one possible place pharma can look for insights into patients? The answer is payers and claims.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment Pharmacy 52

The Pharma Data

NOVEMBER 1, 2020

It is a very exciting step for our Pharmaceutical Wholesale Division and a unique chance for us to further develop innovative services to manufacturers and pharmacists in Germany.”. Together, we look forward to delivering a successful model of operations to benefit the German healthcare ecosystem of patients, pharmacies and manufacturers.”.

Pharmacy 40

Pharmacy Community Pharmacies Pharmaceuticals Licensing 40

Drug Channels

DECEMBER 1, 2020

During 2020, the COVID-19 pandemic disrupted every aspect of the pharmaceutical channel—and our lives. Pharmacy and healthcare provider markets experienced unprecedented volatility. Pharmaceutical wholesalers have maintained shipments and operational capacity. This year has demonstrated the underlying resilience of U.S.

Pharmacy 52

Pharmacy Vaccine Drugs Pharmaceuticals 52

FDA Law Blog: Biosimilars

MARCH 4, 2024

Livornese — On February 6, 2024, FDA issued a draft guidance titled Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or Active Pharmaceutical Ingredients Under Section 506C of the FD&C Act. blood supply; and, Manufacturers of certain finished drug products marketed without an approved NDA or ANDA.

FDA 57

FDA Production Marketing Drugs 57

The Pharma Data

JANUARY 3, 2021

The equipment can also effectively meet the cryogenic storage requirements of various biological samples by most drug distribution companies, hospitals, pharmacies, disease control centers, testing centers, biopharmaceutical companies, scientific research institutes and other institutions.

Vaccine 40

Vaccine Marketing Engineering Production 40

Drug Channels

NOVEMBER 8, 2020

Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more!

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Pharmaceuticals 52

Drug Channels

SEPTEMBER 9, 2021

In Cardinal’s 2021 fiscal year, CVS purchased more than $42 billion in pharmaceuticals from the wholesaler—about double the figure from 10 years ago. The two wholesalers sell more than $90 billion in pharmaceuticals to CVS Health—making it the largest U.S. drug purchaser. to 1:30 p.m.

Pharmaceuticals 85

Pharmaceuticals Marketing Drugs Pharmacy 85

The Pharma Data

NOVEMBER 8, 2020

PAOLI, Pa., — (BUSINESS WIRE) — November 9, 2020 – Sedor Pharmaceuticals, LLC (Sedor) today announced that the U.S. At some hospitals, it can take up to 30 minutes to get a status epilepticus drug from the pharmacy to the point of care in the ER to treat a patient. About Sedor Pharmaceuticals, LLC. About Sesquient.

FDA Approval 52

FDA Approval FDA Long-Term Care Facilities Treatment 52

Agency IQ

MARCH 25, 2024

FDA addressed the expanding practice of drug compounding in 1992 by issuing a compliance policy guide that clarified that pharmacies which compounded products at certain scales, for certain purposes, or without FDA approval were clearly operating “outside the bounds of traditional pharmacy practice.”

FDA 40

FDA Pharmacy Production Drugs 40

The Pharma Data

JULY 29, 2021

The substitution may occur at the pharmacy, a practice commonly called “pharmacy-level substitution” – much like how generic drugs are substituted for brand name drugs, subject to state pharmacy laws, which vary by state. Biosimilars marketed in the U.S. More than 34 million people in the U.S.

Biosimilars 52

Biosimilars Production FDA Approval FDA 52

The Pharma Data

NOVEMBER 10, 2020

He brings to this important role broad international pharmaceutical industry experience, including nearly 10 years in the US. Pablo will report directly to the CEO and serve on the Management Board effective immediately. Almirall US is poised for growth under strengthened leadership. BARCELONA, Spain , Nov.

International 52

International Pharmacy Therapies Marketing 52

The Pharma Data

NOVEMBER 11, 2020

McChesney served as a faculty member at the University of Kansas School of Pharmacy, who presented him with an Outstanding Teaching Award for the 1967 to 1968 academic year. departing in 2003 to become the chief scientific officer for Tapestry Pharmaceuticals and ChromaDex Inc. In 2009, he established Ironstone Separations Inc.,

Organic Chemistry 52

Organic Chemistry Science Pharmacy Pharmaceuticals 52

The Pharma Data

AUGUST 21, 2020

As the pharma community continue to research and develop hundreds of potential therapies to combat the Covid-19 pandemic, very few initiatives are yet to cross the finishing line into the commercial market. REGN -COV2 could be a critical line of defense against the Covid-19 pandemic.”.

Vaccine 52

Vaccine Pharmacy Clinical Trials Virus 52